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ABSTRACT
Improving Evidence Based Asthma Management in an
Urban University Student Health Center
by
Hedian Swanson
Dr. Patricia Alpert, Capstone Committee Chair
Associate Professor of Nursing
University of Nevada, Las Vegas

The purpose of this project was to improve asthma management through focused
staff education and training on national asthma guideline recommendations. The Student
Health Center (SHC), located in a university in the southwest United States, performed
annual reviews of asthma-related electronic medical records (EMR) in an effort to
provide quality health care. These reviews used 23 quality improvement (QI) parameters
extracted from the 2007 National Asthma Education and Preventive Program Expert
Panel Report 3 (NAEPP EPR 3). The SHC QI findings were consistent with current
asthma management literature indicating asthma control is often overestimated and
undertreated. This project (a) provided the SHC staff with ongoing education on the
national guidelines for improved evidence based asthma management and (b) measured
changes in asthma care as reflected in the EMRs. The annual asthma QI data reviewed in
June 2010 established a baseline for comparison and noted weak areas for focused staff
education. Two asthma EMR reviews were conducted in Spring 2011 and in the Fall
2011. The Fall results demonstrated statistically significant improvement from both the
baseline review and the Spring 2011 review. Therefore, staff education is an effective
method for improving asthma diagnosis and management at the SHC.
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CHAPTER 1
INTRODUCTION
Asthma is a chronic inflammatory airway disease affecting all ages. Recently, the
National Center for Health Statistics reported 24.6 million Americans (8.2 %) have
asthma (Akinbami, Moorman, & Liu, 2011). Although asthma is known to be a
reversible disease, studies indicate over time, patients with poorly managed asthma have
lower lung functions, even when asymptomatic, and greater decline with exacerbations
(Chiang & Hsu, 1997; Donaldson, Seemungal, Bhowmik, & Wedzicha, 2002). Student
Health Center (SHC) clinicians (physicians, nurse practitioners, and physician assistants)
manage patients with asthma on a daily basis. Guideline tools are essential to manage
asthma effectively (Tumiel-Berhalter & Hershey, 2005). According to the American
College Health Association (ACHA, 2010), 8.6% of students reported diagnosis or
treatment for asthma by a health professional within the previous 12 months.
ACHA has no specific asthma recommendations; rather, they refer clinicians to
external resources for college policies or government agency guidelines such as those
provided by the Agency for Healthcare Research and Quality (AHRQ). ACHA does
have, however, standards of practice for health promotion in higher education in which
they recommend theory-based and evidence- based practice (ACHA, 2005). Asthma
continues to be a debilitating illness for many students in urban college settings even
when effective treatments are available. University students have access to cost-effective,
quality care at the SHC. Being in an academic institution, the SHC leadership
encourages the use of national guidelines and evidence based practice. Although SHC
providers manage patients with asthma on a daily basis, the diagnosis and management of
asthmatic patients varies among the providers. Furthermore, the utilization of existing
1

resources in the SHC is inconsistent. This capstone project aimed to reinforce the
systematic diagnosis and management of asthma through formal and informal education
of staff and patients by utilizing the National Asthma Education and Preventive Program
Expert Panel Report 3 (NAEPP EPR 3). Effective asthma management improves
students’ symptom control, quality of life, and risk of adverse events. However, the
literature discussing asthma management within a college or university setting is sparse.
Challenges: The Problem
Although the SHC clinicians were familiar with the 2007 NAEPP EPR 3
guidelines, there were no specific clinic guidelines to manage asthma. Systematic
implementation of institutional guidelines influences providers’ treatment decisions for
patients with asthma (Carlton et al., 2005). Implementation of national guidelines
improves some areas of management, such as patient assessment, medication therapy,
and patient education (Self, Usery, Howard-Thompson, & Sands, 2007), but the
implementation may require additional staff training. The SHC performs annual quality
improvement (QI) projects by reviewing electronic medical records (EMR) on various
topics. For the past two years, asthma QI was based on 23 parameters extracted from the
2007 NAEPP EPR 3 guidelines. The QI findings indicated asthma management varied
widely among clinicians and that intake procedures were inconsistent among the nursing
staff. These QI findings were consistent with the concern that more specific clinic-wide
guidelines were needed. To provide high quality asthma care, the SHC aimed to meet QI
criteria for 90% of the patients’ records. The SHC exceeded expectations in certain areas,
but in others, fell below expectations. Less than acceptable scores occurred in asthma
monitoring with a pulmonary function test (spirometry), patient education on medication
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and asthma triggers, appropriate asthma diagnosis for category and severity, and asthmarelated discharge instructions. Intake and documentation by nursing staff more
consistently followed the parameters for current symptoms (chief complaints for the visit),
ACT scores, and peak flow meter readings. The QI review indicated needs for closer
illness monitoring, better documentation, and improved patient education for increased
patient compliance.
Purpose
The purpose of this project was to improve asthma management in an urban
university SHC through focused staff education and training on national asthma guideline
recommendations. Improvement was indicated by compliance with the NAEPP EPR 3
guidelines as measured in an asthma QI review of student EMRs. Compliance with the
guidelines was determined by the presence or absence of 23 quality parameters in the
randomly selected EMRs that contained an asthma diagnosis. Although the providers
received a summary report of the 2007 NAEPP EPR 3, their detailed treatment protocol
for each student was not mandated for the purpose of this project.
Significance of Project and Intervention: Policy Implication
This project in asthma management, which was a collaborative effort between the
SHC staff and their patients, intended to reinforce the SHC clinical staff’s use of
systematic management guidelines for asthma. The author believed that consistent use of
nationally recognized guidelines for evidence based practice (EBP) would increase
patients’ compliance and their quality of life. The SHC is an example of nursing
leadership. It is an advanced practice nurse (ANP)-managed clinic with easy access and
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cost-effective care. This project is an APN initiative to implement evidence-based
practice in asthma care.
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CHAPTER 2
REVIEW OF LITERATURE
The goal of this capstone project was to improve evidence based asthma
management in an urban university student health center by utilizing national guideline
recommendations. To evaluate the SHC’s quality of care for patients with asthma, two
EMR reviews were used to check the SHC QI parameters for asthma management. To
improve asthma management, given the previous years’ QI findings, this author provided
asthma-related staff education to reinforce EBP asthma care. The EMR findings were
compared with previous years QI findings to determine if staff education made a
difference.
This literature review includes general information about asthma; specific issues
about college students; the implications of asthma management guidelines; highlights of
national guidelines; clinical practice guidelines (NGC -5905) specific to asthma diagnosis
and management; provider and patient barriers common to asthma management;
measures for periodic assessment; and patient education.
Asthma
Asthma is a chronic inflammatory disease of the airway that causes reversible
obstruction by narrowing and clogging the air passages due to hyper-responsiveness to
stimuli (National Heart, Lung, and Blood Institute, 2007). Although the exact cause of
asthma is unknown, genetic predisposition and environmental exposure factors seem to
be the main cause. The World Health Organization (WHO) reports that 300 million
people suffer from asthma, that it is the most common chronic illness among children,
and that it occurs in all countries, but over 80% of asthma deaths occur in lower income
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countries (WHO, 2006). In spite of international asthma guidelines (such as Global
Initiative for Asthma) and nationwide U.S. guidelines, asthma is underdiagnosed and
undertreated. The most common causes are indoor and outdoor allergens, tobacco smoke,
chemical irritants, air pollution, cold air, extreme emotional arousal, aspirin sensitivity,
anti-inflammatory drugs, beta-blocker medications, and gastroesophageal reflux disease.
Asthma affects quality of life (Schatz et al., 2007) and productivity, and it causes
economic loss and emotional distress.
Project Objectives and Specific Aims
The goal of this project was improved quality of asthma care as evidenced by
statistically significant increases in the utilization of the national guidelines for asthma
diagnosis and management over two periods of structured staff education and training.
One objective to accomplish this goal was education and training to ensure SHC staff
would be familiar with national guidelines for asthma. Table 1 details the time line for
training, and Appendices A and B provide content examples.
A specific aim of this project was staff utilization of asthma subjective, objective,
assessment and plan (SOAP) charting (see Figure 1) that was to be evaluated as an EMR
review that met the QI parameters (see Figure 2). The SOAP charting could be
completed quickly and easily. Another aim was for SHC clinicians to use an asthma care
action plan in order to assist students with self-management and to include a measure of
frequency in the EMR review QI parameter 5a. Evidence of student education about
asthma management was evaluated by EMR review of positive findings of QI parameters
5c, 5d, 5e, 5h, and 5i. A final aim was an increase in spirometry orders for periodic
monitoring of pulmonary function evidenced by an increase in the number of spirometry
tests performed by the end of each study period. The author had posited that staff
6

education and training on asthma national guidelines would positively affect the
remaining objectives, which would result in improved asthma management by SHC
patients and providers.

SOAP Template
Subjective
Current medication:
Symptoms patient experiences:
Frequency of rescue inhaler use:
Allergy symptoms or triggers:
Home Peak Flow Meter use and readings: yes/No Normal values___ ___ ___
Prior PFT (Spirometry) status: Year_______ Normal/Abnormal
PMH ER visits or hospitalization for asthma:
Objective
ACT score:
Measured Peak Flow readings and SaO2:
Physical exam
HEENT:
Eyes:
Ears:
Nose:
Throat:
Neck:
Cardiovascular Exam:
Respiratory Exam:
Assessment
Asthma diagnosis
Level of asthma
Plan
SVN treatment given: Yes/No Response:
Asthma action plan: Yes/No
Recommend spirometry testing
Medication education: Rescue medication Yes/No
Proper use of controller Yes/No/Wean off
Monitor frequency of rescue medication
Control external triggers (i.e., dust/animal/dust mites/pollens/food/exercise): Yes/No
Referral: Yes/No
Treatment for comorbid condition appropriate for asthma: Yes/No
Follow up: Shorter interval if increased use of rescue medication or new symptoms (e.g.
nighttime awakening)

Figure 1. Asthma visit SOAP note template.
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The 23 Parameters
1. 1a: ACT Score
2. 1b: Current medication
3. 2a: Symptoms patient experiences
4. 2b: Frequency of rescue inhaler use
5. 2c: Indicated allergy symptoms or triggers
6. 2d: Indicated used of home Peak Flow
7. 2e: Prior PF-T status
8. 2f: Indicated PMH ER visit or hospitalization for asthma
9. 3a: Physical exam for upper airway
10. 3b: Physical exam for lung exam
11. 3c: Measured Peak Flow reading and SaO2
12. 3d: Administration of albuterol nebulizer treatment and documented response
13. 4a: Diagnosed with asthma
14. 4b: Documented level of asthma
15. 5a: Indicated written asthma action plan given to patient
16. 5b: Documented education about medications
17. 5c: Appropriately used controller medication
18. 5d: Discussed control of external triggers
19. 5e: Indicated follow up interval
20. 5f: Referred to specialty care
21. 5g: Treated for comorbid conditions appropriate for asthma
22. 5h: Recommended wean off unnecessary controller medications
23. 5i: Recommendation to direct f/u based on rescue inhaler us
Figure 2: Assessment tool: QI parameters. Used with the permission from Pamela Gross,
MD, Ph.D. (Personal communication, November 30, 2010).

Study Question and Assumptions
Does staff education affect quality improvement (QI) of asthma patient care at a
university student health center? A well-documented EMR reflects the quality of care
provided to the patient. Staff Education improves the quality of care provided to patients.
National guidelines, such as NAEPP EPR 3, were developed from random-trial research
studies and systematic reviews of research data. For the purpose of this project, evidence
8

based practice was defined as practice that follows the national guidelines. The 23
parameters used in the QI report accurately measured adherence to the national guidelines.
Population Identification: College Student Issues
During this study, the SHC was utilized by a broad spectrum of age groups, from
young adults to older adults. The patients represented a cross section of society: single
and married with families, international students and locals, gay and straight, commuters
and dorm residents, and the insured and the uninsured. The SHC was located on a
university campus with an enrollment of approximately 27,000 and on-campus residence
chosen by only 5% of undergraduates in 2012. The SHC appointments were based on
same -ay service. All students who paid the student health fee could utilize any clinic
services, but participation in this plan did not cover the cost of procedures, labs, or
medication. Students who purchased additional university sponsored student health
insurance paid 20% of the total costs. However, based on clinic informal estimates,
about 30% of students did not have any health insurance. Without insurance, the SHC
was the only clinic available where students could have access without additional fees to
see clinicians.
The health policy implemented in the Patient Protection and Affordable Care Act
(PPACA) is an attempt at the national level to provide more support for insuring this
group of college students. While research data has been extremely limited, expert
opinion has suggested that making insurance more affordable will, as an interim measure,
increase voluntary rates of insurance until it becomes mandatory in 2014 (Monheit,
Cantor, DeLia & Belloff, 2011). This group has also lacked access to other private
coverage. Most young adults are in good health, but many cannot afford primary care; an
9

unexpected health care need can cause health and financial problems (Kenney & Pelletier,
2008).
College students, as a group, tend to utilize medical services in a different manner
than the general population. They have a tendency to delay treatment of illness until they
have a convenient time, based on class schedule, and when they do seek treatment, they
request immediate access to the service (Grace, 1997). Within this subculture, there are
limited campus-based asthma care studies, and a question arises about how many SHCs
are implementing systematic asthma management by utilizing national guideline
recommendations.
In a. university study conducted by Reece, Holcroft, Faul, Quattrocchi, and
Nicolosi (2002), the researchers reported continued concern regarding undiagnosed
asthma and poorly controlled asthma among the student body. According to the study,
even among the diagnosed asthma patients, there was evidence of inadequate asthma
control; students tended to underestimate the severity of asthma, and were in denial about
the seriousness of this illness. Furthermore, students diagnosed with asthma tended to
see their lower level of functional health as “normal,” and, as a result, they often failed to
practice environmental control and other plans to manage their illness. Although the
students had access to a SHC, many did not utilize this benefit, as indicated by the report
that only 31% of students with severe asthma received their free influenza vaccine. This
particular study also found a positive association between stress and asthma severity.
The impact of persistent asthma illness not only affects physical symptoms, but
also causes emotional disturbance (Duplantier, 2005) and absenteeism (Duplantier, 2005;
Milton, Whitehead, Holland, & Hamilton, 2004; Moonie, Sterling, Figgs, & Castro,
10

2008). Persistent asthma negatively impacts quality of life (Duplantier, 2005; Ford et al.,
2003). Students’ subjective symptom ratings are different from clinical objective
findings, which suggest the importance of individualized educational interventions to
meet the needs of specific students. A comprehensive explanation of asthma progress
and treatment reduces uncertainty regarding the illness (Wolfe-Christensen, Isenberg,
Mullins, Carpentier, & Almstrom, 2008).
A 2002 study indicated that severe asthma caused sleep disturbance, and a
positive relationship was demonstrated between asthma severity and stress. Interestingly,
this study also reported asthma severity did not affect the number of visits to University
Health Services and thus indicated the importance of designing university asthma
programs based on national asthma guidelines that consider the specific needs of young
adults. The authors recommended partnerships between patients and clinicians as keys to
successful asthma management in the university health center. (Reece, et al., 2002)
Although the campus population represents a cross section of society, it has at the
same time a unique culture with pervasive stresses and coping mechanisms that cause
many students to minimize illness symptoms and delay treatment. College health
professionals are in a unique position to educate for health promotion and improved
student health (Grace, 1997). If properly organized along national guidelines, patient
education may be instrumental in improving asthma case management among students.
Project Sponsor and Key Stakeholders
This capstone project fulfills part of the requirements for the doctor of nursing
practice (DNP) curriculum requirements. This author led the study as a full time
advanced practice nurse (APN) employed at the SHC. This project served as a
11

continuous quality improvement (CQI) project for the SHC. There was no specific
project sponsor; instead, this project was carried out as a collaborative effort with SHC
leadership and staff. The CQI participants were SHC staff, but the main stakeholders
were students with asthma.
Organizational Assessment
There were about 18,000 SHC visits during the 2010-2011 academic year. The
SHC is situated within a cluster of wellness center services and shares facilities with
campus recreation services and a counseling center. Student fees support the services
offered by the student wellness cluster. The SHC is fully accredited by the Accreditation
Association for Ambulatory Health Care, and it has a lab and pharmacy in house.
Information technology staff provides services to the entire wellness cluster. The SHC
also employs a care manager for referral follow-ups and patient assistance programs. The
SHC provides sports medicine on a part-time basis, gynecological services for specific
needs, and dermatology care by specialists. Appointments are based on same-day service.
All students who pay the student health fee can utilize any clinic service, but the cost of
procedures, labs, or medications are not covered. The available spirometry computer
program was complex and not user friendly. No new spirometry equipment was
purchased for this project. Each exam room had peak flow meters with disposable
mouthpieces. The lab manager routinely cleaned the peak flow meter (PFM) with a
bleach solution.
The mission of the SHC was to help students achieve their highest level of
wellness and optimize their potential for academic success. The institution had
established SHC goals and objectives that were aimed towards providing credible, cost12

effective healthcare through effective clinical services as well as excellent customer
service to students. In pursuit of providing quality care, clinicians participated in
continuing education activities, peer EMR reviews, and annual QI projects. The recent
initiation of the asthma QI project added to the SHC’s effort to provide evidence based
health care delivery to the university students.
Implications of Asthma Management Guidelines
For the purposes of this capstone project, utilizing 2007 NAEPP EPR 3 was
feasible and safe because the published national guideline recommendation was based on
a stringent review of research studies. The national guidelines for accurate diagnosis,
prescriptions for appropriate therapy, monitoring for disease control, and referrals to
specialists as needed helped providers improve their patients’ asthma control. In a survey
program for clinical benchmarking of chronic care measures, ACHA recommended that
health centers do chart reviews based on National Heart Lung and Blood Institute
(NHLBI) guidelines, which addressed asthma care and documentation, measurement of
airflow obstruction through peak flow or spirometry, provision of a patient action plan,
and assessment of the effectiveness of controller medication (ACHA, 2009).
The practice environment affects adherence to the national guidelines for asthma.
While providers generally perceived the guideline as useful, many reported a lack of tools
to provide appropriate care except for peak flow meters and standard history forms
(Tumiel-Berhalter & Watkins, 2006). A systematic implementation of the NAEPP EPR 3
practice guideline improved providers’ prescribing of controller medications due to
appropriate assessment of the severity of the illness in uncontrolled patients (Carlton, et
al., 2005). Literature related to emergency department asthma protocol use indicated the
13

NIH-based protocols were effective in improving the quality of patient assessment and
appropriateness of therapy, but the protocols were not effective in changing providers’
prescribing habits (Self, et al., 2007). The protocol use was enhanced when ER staff
followed a simplified form and received consistent reminders (Self, et al., 2007). An
evaluation of asthma management in a public school that was based on the NHLBI
guideline indicated poor adherence and lack of consistent strategies and needs for
education and policy development (Snow, Larkin, Kimball, Iheagwara, & Ozuah, 2005).
While evidence based practice (EBP) plays a part in improving care, there is a need for
further evaluation of the strength, relevance, and sensitivity of the evidence based
guideline in order to meet patients’ unique needs and to safely practice (Nolan & Bradley,
2008).
NAEPP EPR 3
Beginning in 1991, the NAEPP of the NHLBI prepared guidelines for the
diagnosis and management of asthma in order to bridge the gap of current knowledge and
practice. The NAEPP released its latest updated EPR 3 in 2007, and it was based on
current scientific evidence. Although asthma prevalence has increased over the years, the
NAEPP reports that since it released its initial guideline, the number of deaths due to
asthma has decreased, the incidence of activity limitations have decreased, and formal
asthma education has increased. Due to the SHC population’s age, this summary will
focus on adult-related recommendations. The national guidelines focus on achieving and
maintaining control of asthma so patients have a high quality of life and minimize lung
function deterioration over time.
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NAEPP EPR 3 has provided several updates to its recommendations. For
example, accurate asthma diagnosis should be made through a thorough medical history,
a physical examination to determine any recurrent episodes of airflow obstruction, use of
spirometry in all patients ≥ 5 years of age to assess reversibility based on FEV1 measure
and differential diagnosis to rule out other possibilities such as COPD or vocal cord
dysfunction in adults. When the patient is not on preventive medication, the severity
classification is used to guide initial therapy. The goal of asthma treatment and long-term
management is to control the symptoms. Symptom control reduces impairment as
manifested by reduced use of short acting beta agonist (SABA), maintenance of lung
function, and ability to engage in normal daily activities. In addition, symptom control
prevents exacerbations, minimizes hospital visits, prevents loss of lung function, and has,
ideally, no or minimal adverse effects from medication therapy.
Under EPR 3, current impairment and future risk assessment have been added to
the component of severity. The severity was simplified to intermittent or persistent;
persistent was subdivided into mild, moderate, or severe asthma for youth ≥ 12 years of
age and adults (see Figure 3). EPR 3 recommends inhaled corticosteroids (ICSs) for
persistent asthma and a step up if needed after checking adherence, environmental control
(See Figure 4), and comorbid conditions. The clinician will assess control (See Figure 5)
and step down if possible when asthma is well controlled at least for three months (see
Figure 6). Due to the recent safety data, long acting beta agonist (LABA) should not be
used as monotherapy; omalizumab (Xolair) has been added to step 5 and 6 treatment
consideration for this age group.

15

Asthma education is integrated into all aspects of patient care and is an ongoing
partnership between the clinician and the patient. It is important to understand the
patient’s level of literacy and their cultural practices. Subjects for patient education
include a written asthma action plan, education about self-monitoring to assess level of
control, correct use of medications, avoidance of environment triggers, and the
importance of influenza vaccine and treatment of comorbidity (NHLBI, 2010).

Figure 3. Classifying asthma severity and initiating treatment in youth ≥ 12 years of age
and adults.
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Figure 4. EMR - Asthma triggers.
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Criteria for well-controlled, not well-controlled, or very poorly controlled asthma in
children aged 12 years or older. Level of control is based on the most severe
impairment or risk category. Assessment of the impairment domain is based on the
patient's (or caregiver's) recall of incidents during the previous 2 to 4 weeks and by
spirometry or peak flow measures for patients aged 5 years or older. Symptom
assessment over longer periods should reflect a global assessment, such as
determining whether the patient's asthma is better or worse since the last visit. ACQ
= Asthma Control Questionnaire; ACT = Asthma Control Test; ATAQ = Asthma
Therapy Assessment Questionnaire; EIB = exercise-induced bronchospasm; FEV1 =
forced expiratory volume in 1 second. ACQ values of 0.76-1.4 are inconclusive
regarding well-controlled asthma. From Expert Panel Report 3: Guidelines for the
Diagnosis and Management of Asthma.

Figure 5: Assessing asthma control and adjusting therapy in youth ≥ 12 years of age and
adults. Source: National Heart, Lung, and Blood Institute (2010, p. 270).
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Figure 6. Stepwise approach for managing asthma in patients aged 12 years or older. EIB
= exercise-induced bronchospasm; ICS = inhaled corticosteroid; LABA = long-acting βagonist; LTRA = leukotriene receptor antagonist; SABA = short-acting β-agonist. From
the National Heart, Lung, and Blood Institute (2010, p. 268), Expert Panel Report 3:
Guidelines for the Diagnosis and Management of Asthma.
Asthma Clinical Practice Guidelines NGC-5905 & AGREE Critique
The National Guideline Clearinghouse (NGC) helps clinicians evaluate the
strength of national guideline recommendations. NGC-5905, “Measures of asthma
assessment and monitoring: Expert panel report 3: guidelines for the diagnosis and
management of asthma” is useful for developing clinical practice tools and education
materials; and it provides a stepwise approach in management of asthma based on
cumulative scientific evidence (see Appendix D). This guideline was valuable for the
SHC as it initiated systematic implementation of national recommendations, and, as the
19

SHC adapted to the students’ situations in order to improve compliance, it provided
appropriate flexibility in implementation.
NGC-5905 clearly delineated intervention and practice considerations through
diagnostic parameters, management/evaluation/risk assessment, and guidance for the
major outcomes that needed to be considered. The guideline utilized a weighted rating
scheme (Evidence A to D with A being the strongest) for the strength of the evidence
based on the review of literature which included randomized controlled trials and a rich
body of data findings. However, the NAEPP EPR 3 lacked formal cost analysis. Asthma
control is defined by reduced impairment as a result of preventing chronic and
troublesome symptoms, by infrequent SABA use (≤ 2 days a week), by maintenance of
near or normal pulmonary function test (PFT) results, by maintenance of normal activity
level that meets patient and families’ expectations for asthma care (Evidence A). It is
important to monitor pulmonary function periodically (Evidence B for extrapolation from
clinical trials and Evidence C from observation studies). The frequency strength is
helpful for the SHC, because performing PFT (spirometry) for every visit may not be
feasible for students due to cost and time constraints (NGC, 2007). The recommendation
for spirometry testing is one of the 23 parameters used in this project.
The 23 Parameters
The EMR reviews were done by evaluating sample records for presence, absence,
or not applicable (NA) status of 23 parameters for asthma management (See Figure 2). A
physician who was a former employee drafted the parameters; she performed the initial
asthma EMR review utilizing this tool. The validity of these parameters has not been
tested. Due to the limited time period for this capstone project and the SHC staff’s
20

familiarity with these parameters, this author decided to use this existing tool with
permission from the physician who designed it.
The parameters are divided into five categories based on the NAEPP EPR 3
recommendations. The categories are organized to correspond with the EMR
documentation sequence of subjective and objective data, assessment and evaluation,
which includes patient education and discharge instructions. The first and second
categories are to obtain a thorough asthma related history and provide routine asthma
care during the intake. It includes patient symptoms, known triggers, current medication
list, observed triggers and resultant frequency of SABA use, home peak flow meter use,
prior pulmonary function test status (PFT/Spirometry) and emergency room or
hospitalization history. Intake medical assistant or nurse records the asthma control test
(ACT) score. The third category is the physical exam that includes upper and lower
airway, measurement of peak flow readings, pulse oximetry and documentation of patient
response if SABA treatment was included. The fourth category is documentation of
asthma diagnosis and asthma severity level. The last category focuses on patient
education, specialty referral if necessary and, if present, treatment of comorbid conditions.
For the purpose of this study, patient education includes an asthma action plan,
appropriate use and monitoring of SABA and LABA, trigger control, and appropriate
follow up intervals.
The parameters reflect the basic national guideline recommendations. This author
recognizes it does not cover all the recommendations from NAEPP EPR 3. For example,
parameters for influenza or pneumonia vaccines are not included. However, the SHC
offers free influenza vaccines to all students. Clinicians when appropriate, especially for
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the patients with persistent asthma, recommend pneumococcal vaccine. Pneumococcal
vaccine is available at the SHC fir a reasonable cost. In addition, routine functional
assessment with pulse oximetry for SaO2 percent for patients without asthma
exacerbation is not necessary (NHLBI, 2010). Pulse oximetry can be useful for children
who are not able to perform PFT or PEF < 40% of predicted. A serial pulse oximetry is
useful during exacerbation and improvement of treatment (Evidence B). However, single
pulse oximetry value has relatively little value (NGC, 2007). The 23 parameters will be
revised to meet the needs of SHC, but as currently constructed provide guidance to
evaluate asthma diagnosed EMRs for the early stage of CQI within the SHC.
Provider and Patient Barriers
Uncontrolled asthma can be a burden to patients, affecting their quality of life,
result in decreased productivity from missed work/school (Dean, Calimlim, Kindermann,
Khandker, & Tinkelman, 2009) and may also become a financial burden (Accordini et al.,
2006). In a Spanish study, adult asthmatic patients were more likely to be sub-optimally
controlled (71%) compared to children (53%), and patients who were managed by a
specialist were better controlled than those managed by a general practitioner (Prieto et
al., 2007). Achieving a controlled state is a challenge due to multiple barriers. One
barrier is a discrepancy in symptom control definition between providers and patient. For
example, a study (Green, 2010) of 1276 patients in an asthma control test (ACT)
indicated providers considered asthma control at about 30%, where as 50% of the patients
thought their symptoms were controlled.
Another barrier might be clinicians’ limited adherence to National guidelines.
Among providers who perceived the national guidelines as useful, there was improved
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adherence to implementing spirometry, use of peak flow meters, patient assessment,
action plans, severity assessment, and use of anti-inflammatory medications (TumielBerhalter & Watkins, 2006).
The common provider barriers to effective asthma management are a lack of
patient education, prescribing habits that rely on SABA when there is need for ICS
(Elliott, 2006) and result in under treating persistent asthma (Moonie et al., 2005), overestimate of control, inadequate follow up ,and lack of monitoring such as pulmonary
function tests. Although prophylactic medication is used for persistent asthma and has
been shown to reduce morbidity and mortality, adherence to anti-inflammatory
medication was often <50% in United Kingdom (UK) studies (Elliott, 2006). One study
indicated 88% of clinicians were aware of national asthma guidelines, but self-reported
compliance ranged from 39% to 53% due to various barriers (Cabana, Rand, Becher, &
Rubin, 2001).
The common patient barriers to care were literacy level, environmental triggers,
support system, and economic concerns (Kallstrom, 2007). Bender and Bender (2005)
reported additional barriers to care including concerns about drug safety and cost, beliefs
that minimized the severity of asthma, and concerns about medication dependency.
According to Green (2010), the common patient barriers in South Africa were failure to
recognize disease chronicity, abuse of over-the-counter medications, noncompliance,
inability to use delivery devices, fear of adverse events, and cost issues. The adult patient
group’s barriers to adherence to asthma treatment in the UK were similar to the South
African findings (Elliot, 2006). In addition, it was noted that adults’ noncompliance with
an asthma management plan was related to “belief that the medication does not work or is
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not necessary; sense of only intermittent need, inconvenience, cost of medication, dislike
of provider, interference of life hassles, [and] distrust of medical establishment” (Elliott,
2006, p. 225). One study reported personality traits such as negative affectivity and
impulsivity correlated negatively with asthma control (Axelsson et al., 2009), which
reminds providers of the importance of individualized management.
Asthma Control Test (ACT)
NAEPP EPR 3 recommends patients utilize self- assessment tools to improve the
accuracy of their perception of asthma control. Self-assessment questionnaires are useful
tools that can be completed during the visit. Several self -assessment tools (i.e. Asthma
therapy Assessment Questionnaire, Asthma Control Test, Asthma Control Questionnaire,
Asthma Therapy Assessment Questionnaire, Asthma Control Test, Asthma Control Score)
measure the impairment and the risk domains of asthma. Not all studies measure both
impairment and risk domains. The ACT is a simple self-evaluated symptom assessment
tool that can assist patients and providers to evaluate the state of both the impairment and
the risk domain. The possible total score ranges from 5 to 25, and score of ≤ 19 indicates
suboptimal control. ACT identifies area of quality of life, frequency of symptom,
severity, frequency of SABA use and self-perceived asthma control. The ACT
questionnaire is a valid, easy to use tool that provides evidence to support clinical
decision-making (Halbert, Tinkelman, Globe, & Shao-Lee Lin, 2009; Ko et al., 2009).
According to a study based in Japan, the ACT score predicted the risk of future
exacerbation within one year (Sato et al., 2009). While FEV1 is used as an indicator of
asthma control during the pulmonary function test, studies indicated a positive correlation
between the ACT score and FEV1 (Ko et al., 2009; Leung et al., 2009). However,
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NAEPP EPR 3 indicated currently available instruments have not had a standardized
assessment for validity and reliability (NHLBI, 2010, p. 50). Although the ACT is not a
comprehensive test, it complements other assessments obtained during the visit and the
SHC staff members are familiar with this test and find it easy to score.
Peak Flow Monitoring vs. Symptom-Based Monitoring
The peak flow meter is a handheld device that measures forced expiratory volume.
The evaluation is based on gender, age and height; depends on effort and technique; and
is not considered a diagnostic tool (NHLBI, 2010), but it is useful for ongoing selfmonitoring that may alter an asthma management plan. Long-term peak flow monitoring
is recommended for moderate or severe persistent asthma (Evidence B), history of severe
exacerbations, poorly perceived airflow obstruction, and worsening asthma. In addition,
peak flow monitoring is important during asthma exacerbation (NHLBI, 2010). NAEPP
recommends a written asthma action plan if peak flow is used. Written asthma action
plans can be based on either symptoms or peak flow measurements (Evidence B, NHLBI,
2010, p. 94). Although students often reply they used a peak flow meter in the past,
especially during childhood, they no longer have the device and do not know their
personal best value. Even among the students with persistent asthma, it is challenging to
monitor home peak flow daily. For that reason, the SHC providers often rely on the
patients’ reported symptoms and then monitor peak flow readings during the visit. Either
peak flow or symptom monitoring may be equally effective if taught correctly (Evidence
B), and either way, self-monitoring is important for self-management of asthma
(Evidence A). NAEPP EPR 3 recommends the frequency of visits be up to the clinician
based on the patient’s symptom control status. For patients with intermittent and mild,
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persistent asthma, symptom control should be undertaken for at least three months and
appointments should be scheduled every six months. However, patients whose asthma
symptoms are uncontrolled, and those patients whose symptoms are severely persistent
need closer observation.
Asthma Action Plan
A written asthma action plan is recommended for all patients with asthma and it
should include daily routines, which help the patient recognize worsening symptoms and
effectiveness of disease management. This is especially important for patients with
moderate to severe persistent symptoms, a history of severe exacerbation, or a history of
poorly controlled asthma (Evidence B). Although there have been inconsistent studies
regarding written asthma action plans, NAEPP EPR 3 recommends the use of a written
asthma action plan that is suitable for the practice setting and a plan that is communicated
in a patient education setting between patients and providers. The written asthma action
plan (See Figure 7) should include the following information: short and long-term
medications, actions to control environmental factors, recognition of worsening
symptoms, how to respond to worsening symptoms, urgent medical care needs, and
phone numbers for emergent situations. The written asthma action plan should be
reviewed and updated during each visit (NHLBI, 2010).
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Figure 7. EMR Asthma Care Action Plan.

Spirometry
Spirometry is a pulmonary function test which measures the volume and flow of
air that is inhaled and exhaled in a given time period for children ≥5 years. Besides
monitoring other chronic lung diseases, it is a useful diagnostic tool for asthma as well as
a means to assess the severity of symptoms and measure reversibility after SABA
treatment. The measurement indicates normal, obstructive, restrictive, and a combined
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obstructive/restrictive pattern. The most often used measurements are forced expiratory
volume in one second (FEV1), forced expiratory volume in six seconds (FEV6), forced
vital capacity (FVC), and the proportion of the air blown out in one second to the total
volume in one breath (FEV1/FVC). FEV1 is an important flow index for asthma control.
A study that assessed the relationship between pulmonary function, bronchial hyperresponsiveness, and atopic dermatitis in children with stable asthma found children with
stable asthma had lower lung function in all levels (intermittent or persistent) compared
to children without asthma (Yang et al., 2006). Sato et al. (2009) searched for probability
of future asthma exacerbation; their study assessed the usefulness of self-assessment
along with an objective measure. Their findings indicated combining spirometry with the
ACT score provided statistically significant predictions. Patients with an FEV1 ≤ 91.8%
and an ACT score ≤ 23 were demonstrated to be at risk of exacerbation within one year
(Sato et al., 2009).
The recommended frequency of spirometry by NAEPP EPR 3 is as follows: at the
time of initial visit (Evidence C); after the symptom has been stabilized; during the
exacerbation; and at least every one to two years subsequently to assess the maintenance
of lung function (Evidence B). However, spirometry may be used more often depending
on severity of symptoms and response to management (Evidence D). Lung function
declines gradually starting in adulthood, but asthmatics have greater decline on average
(Chiang & Hsu, 1997). Spirometry is helpful for observing lung function over time. The
SHC providers recommended spirometry during the initial visit, to assess prognosis of
illness, and at least once a year.
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Patient Education
Asthma education improves patient compliance with medication (Delaronde,
Peruccio, & Bauer, 2005) and improves the morbidity pattern (Mishra, Rao, & Padhi,
2005). One of the systematic research reviews for children reported school wide asthma
education enhanced patient and school employee knowledge of asthma, but had less
consistent positive health outcomes, possibly due to a lack of environmental control
(Coffman, Cabana, & Yelin, 2009). This report recommended creatively disseminating
self-management education programs as a partnership between patients and providers,
which would be integrated into a comprehensive approach to medical care.
Clark and Partridge (2002) illustrated how surrounding the patient in an asthma
management support system to strengthen asthma education could enhance disease
control. The system included “Family Involvement, Clinical Expertise, Work/School
Support, Community Awareness and Action, Community-wide Environmental Measures,
Conducive Policies and Effective Business Practice” (Clark & Partridge, 2002, p. 1662).
The system depicts the importance of provider involvement in patient centered education
to achieve disease control.
Several other studies have investigated asthma education programs. A study of
young adults in Finland indicated the degree of patient asthma education can be affected
by childhood living conditions and economic adversities (Kestila et al., 2005). The
researchers concluded that recognizing childhood experiences could play an important
role in preventing health problems in adulthood. Another study found providing both
audio and print educational materials enhanced patient adherence to medication (Schaffer
& Tian, 2004). Accordingly, a written action plan such as the one in Figure 9 provides
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the patient with knowledge on how to manage symptom exacerbation as well as how to
cope with the disease day to day.
Student education should be a part of every routine visit. As illustrated in
Appendix A, it may include teaching or reviewing correct medication use monitoring
peak flow, planning asthma action planning, understanding the importance of annual
influenza vaccination, controlling the environment, modifying life style (such as smoking
cessation), and treating comorbidity (such as seasonal allergy symptom control).
Synthesis
Asthma is a chronic inflammatory airway illness affecting over 300 million
people globally (WHO, 2006), and although the exact cause of asthma is unknown,
genetic predisposition and environmental exposure are generally accepted as the main
culprits. Uncontrolled asthma not only results in economic loss but also negatively
affects quality of life and productivity. The university SHC manages asthma on a daily
basis. Although asthma is not one of the top 10 diagnoses encountered at the SHC,
providing evidence based care has been an ongoing effort. SHC providers are
knowledgeable about the national asthma guideline recommendations, but it is
challenging to comply with these recommendations due to student and provider barriers.
This project used 23 parameters extracted from NAEPP EPR 3 to compare the
findings before and after staff interventions of two QI asthma diagnosis EMR reviews.
While the tool has not been validated, it has served as an important tool to implement the
initial phase of asthma CQI at the SHC. Due to the unique circumstances of student life,
it is the SHC’s intention to take every opportunity to educate students about asthma
management and symptom control as it relates to their quality of life. NAEPP EPR 3 is a
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set of well-known national guidelines the SHC can follow to diagnose and manage
asthma. ACHA (2009) recommends SHCs to follow national guidelines in caring for
students with asthma. NAEPP EPR 3 emphasizes accurate measurement of severity in
order to initiate appropriate treatment and management by “step up” treatment for
uncontrolled asthma, and “step down” treatment for well-controlled symptoms. NAEPP
EPR 3 recommends ICS for initial persistent asthma treatment. All patients being treated
for ICS need SABA, and they should be instructed appropriately in its use.
NGC- 5905 (NGC, 2007) is a concise critique resource for evidence based
measures of asthma assessment and monitoring based on EPR 3. It evaluates the strength
of guideline recommendations for asthma diagnosis and management. Periodic
assessment measures such as ACT scoring, peak flow meter monitoring, spirometry and
asthma care action plans assist students to objectively monitor symptoms and manage
their care. As demonstrated in this project, CQI is a patient-centered process of executing
a continuous flow of improvements as well as a motivation for staff to provide improved
health care within an organization.
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CHAPTER 3
THEORETICAL UNDERPINNINGS OF THE PROJECT
JHNEBP and Deming’s PDSA Cycle
This project was guided by the framework from the John Hopkins Nursing
Evidence Based Practice (JHNEBP) Model and Deming’s Plan-Do-Study-Act (PDSA)
cycle (Deming, 1993) as a model for CQI. With the understanding of an APN, the author
based the foundation of this project on evidence based, systematic nursing knowledge.
JHNEBP and the PDSA cycle complemented the CQI process. JHNEBP provided
systematic guidance from identification of an EBP question to communication of the
findings. In addition, the PDSA cycle was a feasible, simple, visible way to implement
CQI for an organization where multidisciplinary staff members had a part in this project.
The JHNEBP was developed to help nurses understand and utilize the basic
principles of evidence based practice for decision making in patient care. Its goal is to
facilitate implementation of effective nursing interventions, efficient care, and improved
outcomes for patients. The JHNEBP Model (Figure 8) utilizes a formalized process to
develop a practice question, gather evidence through research findings, and develop an
action plan to implement changes based on the findings (Newhouse, Dearholt, Poe, Pugh,
& White, 2007).
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Figure 8. The Johns Hopkins Nursing Evidence-Based Practice Model (JHNEP). Copied
with permission from the Institute for Johns Hopkins Nursing.
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Figure 9. The Johns Hopkins Nursing Evidence-Based Practice Process. PET (Practice
Question, Evidence, and Translation). Copied with permission from the Institute for
Johns Hopkins Nursing.

In 18 steps arranged in three sets (Figure 9), this model guided the project
systematically from conceptualization to conclusion. Using PET (practice question,
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evidence, and translation) as a tool for quality improvement (QI) in the SHC treatment of
asthma patients provided a pathway to document the use of EBP. This model is an open
system that recognizes results of the project are influenced by input from both external
and internal factors. The external factors, such as accreditation, quality measures
(outcome and performance data), regulation, standards, and legislation, influence the
system. Results are also influenced by internal factors: culture, environment,
equipment/supplies (specifically peak flow meters and spirometry, electronic medical
record systems, and nebulizer machines), and staffing levels required to provide efficient
care and maintain high standards (Newhouse, et al, 2007).
The first five steps of the JHNEBP model are grouped under the practice question
section. They helped determine the purpose and the scope of the project, and determine
who would be carrying out the objectives. While “secure support from decision
makers…” is listed as Step 16 in the translation phase of the project, support from the
SHC director and leadership team was essential from the beginning. This support
allowed the author to recruit SHC colleagues as project team members and receive
departmental resources, including staff training time, in the project.
Steps six through ten involve the gathering of evidence as documented in the
literature review. Internal evidence included previous QI findings on asthma treatment,
and extensive external data, which included peer-reviewed studies, national guidelines
such as NAEPP EPR 3, and clinical practice guideline (CPG) NGC 5905. An appraisal
of guidelines for research and evaluation (AGREE) appraisal was used to validate the
strength of NGC 5905. Based on internal and external evidence, a plan was presented to
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the SHC director for improving asthma management with results to be evaluated in
subsequent QI findings.
The remaining eight steps provided guidance for testing the practice question,
then implementing and evaluating the effectiveness of the intervention. Positive
outcomes from the intervention are presented to the SHC leadership for implementation
as an ongoing policy. The final step in the JHNEBP model involves sharing the findings
internally and making them available externally for further research.
CQI
CQI is a patient-centered process within a particular organization supported by
the organizational strategic plan. Its purpose is to provide quality health care that meets
or exceeds expectations for executing a continuous flow of improvements. Since the
Institute of Medicine (IOM) initiative to reduce medical error (IOM, 2001) was
introduced, institutions have invested resources to reduce medical errors and thereby
increase quality of care and patient safety (McLaughlin & Kaluzny, 2006). CQI does not
happen quickly, but rather evolves over time. Management and employee buy-in is
necessary for a successful outcome. For specific care-process improvement, staff
training is necessary. Analysis and redesign of the product (if necessary) lead to
implementation of a consistent policy that uses evidence based practice. CQI provides
several benefits for health care management. It can help motivate staff to improve
performance because there are objective metrics that can be measured to compare one
year to another.
Deming’s PDSA cycle is a dynamic four-step management method that has been
used for CQI in many businesses and service arenas. It is sometimes known as the
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Deming cycle, the Shewhart cycle or the plan-do-study-act (PDSA) cycle. In its basic
form, PDSA is a four-step cycle for problem solving that includes: (1) Plan—a change or
a test, aimed at improvement (2) Do—carry out the change or the test (preferably on a
small scale); (3) Study--evaluate the result; and (4) Act—Adopt the change, or abandon it,
or run through the cycle again (Deming, 1993). PDSA is a continuous process for
learning and improvement based on the belief that knowledge and skills are limited, but,
by repeatedly implementing the cycle of improvement, each cycle brings the organization
closer to the goal of perfection (Moen & Norman, 2010). Study of the weak areas
evidenced by comparing the 23 parameters to actual EMRs is part of the Planning cycle
and indicated limited documentation of asthma treatment and inconsistent treatment. The
Do cycle included staff training, checklists, and providing templates in the EMR for
patient education. The Study cycle is accomplished during the annual EMR review with
grading of the 23 QI parameters. The Act cycle involves institutionalization of successful
processes introduced in the Do cycle (see Figure 10).
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Act – Adopt the change,
or abandon it, or run
through the cycle again

Study – the results.
What did we learn?
What went wrong?

Plan a change or
test, aimed at
improvement

A

P

S

D

Deming’s PDSA Cycle (Deming, 1993, p.132: Used
with permission from The MIT Press, see Appendix
G)

Share the EMR
review findings
with staff, plan
for areas of
improvement &
implement

Current asthma
mangement
EMR review &
CQI plan by APN

Biennial EMR
review by clinical
staff & evaluate

Implement
asthma
management
guided by NAEPP
EPR 3

Adapted from Deming’s PDSA Cycle (Deming,
1993: Used with permission from The W. Edwards
Deming Institute)

Figure 10. Asthma CQI cycle based on Deming’s PDSA.
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Do – Carry out the
change or test
(Preferably on a small
scale)

The CQI is a collaborative process with many stakeholders from a variety of
disciplines, but the focus must always be on the needs of the patient. Nursing staff
encounter patients at the beginning, in the middle of the treatment process, and at the
patient discharge stage. The nursing function is not limited to taking vital signs, but
includes measurement of peak flow meter reading (PFM), obtaining an asthma control
test (ACT) score and taking a history for current medications, including over the counter
allergy or asthma medications. Nursing staff should be trained to perform accurate
spirometry testing and patient education. The history Section includes documentation of
the symptoms which a patient experiences, comorbidity and triggers, home monitoring,
assessment of short acting beta agonist (SABA) frequency of use, past PFT and past
medical history related to asthma exacerbation. The exam section includes upper and
lower airway exam, peak flow reading/SaO2 and documentation of post SABA treatment
response. Because of their high level of patient contact, the professional nurse is a key
player in CQI. The assessment section includes appropriate parameters for
documentation of asthma type and level of severity. The last plan section includes
documentation of an asthma action plan, patient education, referral when necessary,
appropriate follow up visit intervals, comorbid management, environmental control, step
up and down treatment plan and monitoring spirometry as part of PFT. This chart
illustrates a typical primary care clinic asthma flow chart, which is self-explanatory (see
Figure 11). CQI is a cyclical process in which all the stakeholders continually refine their
parts in order to provide quality and safe patient care.
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Patient

Intake

Clinicians

• Symptom presentation
• Medication refill

• Routine intake/discharge plus:
• ACT Score, Peak Flow Meter, Pulse Oximetry
• Assist with spirometry scheduling
• Provide an appointment card whenever possible
• Patient education
• Print 3 patient information materials before seeing the patients & use it as
education material
• Asthma Action Plan, Triggers & Spirometry handouts in EMR under education
• Utilize asthma subjective form for Hx gathering
• Physical Exam
• Prescribe appropriate treatment and educate
• Recommend spirometry and schedule: Tues pm & Thur am; $20 (Pre & Post is
$37)
• Recommend free influenza & pneumo ($65) vaccines
• Recommend follow up intervals
• Utilize asthma discharge check list

Figure 11. Asthma Management Flow Chart
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CHAPTER 4
PROJECT AND EVALUATION PLAN
Background
Annual QI EMR reviews based on 23 QI parameters were conducted on asthmatic
student EMRs at the SHC. For the purpose of this study, the same assessment tool was
utilized. While the validity and reliability of this assessment tool has not been studied,
these parameters closely parallel the 2007 NAEPP EPR 3 recommendations. The SHC
has set a goal of meeting 90% satisfaction when it performs QI. During the 2009-2010
academic year QI EMR review, four parameters (listing of current medication, patient
symptom, lung exam, having asthma diagnosis, and suggested follow up visits) met this
expectation. Poor performance parameters were: taking prior PFT history, prior asthma
related hospitalization history, documentation of SABA treatment response, severity of
asthma diagnosis, written asthma action plan, recommendation of weaning off ICS for
controlled asthma and follow up based on increased SABA usage. These findings are
similar to the previous year’s QI review. The asthma QI review results were presented to
the staff with discussion about areas of improvement.
Since Fall 2010, staff education focused on those areas which needed
improvement based on the previous year’s QI. SHC resources for asthma management
have improved with addition of a spirometry clinic offered two half days weekly.
Providers now have access to asthma action plan templates. The providers at the SHC
adopted parts of the national guidelines based on their knowledge and comfort level.
Throughout 2011, staff education on asthma care was implemented, and it was
reinforced as an ongoing process. The author presented general asthma topics such as
spirometry technique and interpretation, use of peak flow meter, measuring data, and
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writing an asthma action care plan during staff and provider meetings. There were
occasions a local allergy/asthma specialist presented asthma topics relevant in the past
year. The specialist also provided additional educational sessions on spirometry
interpretation. All providers received a copy of the NAEPP EPR 3 summary report
booklet published by the National Institute of Health (NIH) at the beginning of 2011.
Project Plan
Setting and Population of Interest
The research setting is a SHC in an urban, public university with an enrollment
greater than 25,000 students. During the 2009 – 2010 academic year there were
approximately 19,000 clinic visits. This study includes EMR data only from those
students who utilized the SHC for asthma related visits. The focused education is
targeting SHC staff who provide care for these students.
Measures, Instruments, and Activities
Initially, all EMRs in the SHC database with asthma diagnosis during the two
study periods were retrieved. Then EMRs with exercise-induced asthma (EIA) and
patients younger than 18 years of age were excluded. Including EIA EMRs would add
more variables to the study because exercise frequency could skew the data. Depending
on the size of the pool, a systematic random formula was used to select records for
evaluation such that 50 EMRs were selected for inclusion in the study. From the 20092010 academic year, 25 asthma EMRs were randomly selected for an in-house QI review.
The limited number of records reflected constraints of available reviewer time to process
the results. At the initiation of the project, 50 records were selected for each review with
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the 2009-2010 QI results noted as a baseline. A post hoc power analysis suggested 50
EMRs were adequate for the analysis.
Utilizing the pre-existing asthma QI instrument, the author conducted two EMR
quality reviews at the end of the spring and at the end of the fall semesters 2011. The
SHC utilized these criteria for two previous annual asthma QI reviews and the staff was
familiar with this instrument. A clinician who was not conducting this capstone project
selected EMRs for review in order to reduce reviewer bias and avoid data bias.
Throughout the period of the capstone study, the SHC staff received education and
training on evidence based care for asthma management as noted in Table 1. The
findings Fall 2011 were compared with the baseline QI results and with the Spring 2011
results.
Use of the pre-existing QI instrument tool permits consistent data comparison to
determine if ongoing staff education has improved adherence to the national guidelines.
This instrument does not contain copyright material. It was developed specifically to
evaluate adherence to NIH guideline recommendations at the SHC.
Methods
This study used descriptive statistics (e.g., percentiles, frequencies, and
correlations). The identified EMR parameters were initially evaluated as a symbol of the
presence/absence of the criteria in the QI flow sheet (see Figure 12). Once the 50 EMRs
were evaluated, each criterion (23) was calculated as a percentage of positive findings by
using the Statistical Package for the Social Sciences (SPSS) version 17 (Cronk, 2008) for
frequency distributions and percentile ranks. The difference between the before (i.e.,
both the baseline and the Spring 2011) and after (i.e., Fall 2011) percentile scores were
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compared in terms of statistical significance in order to evaluate the effect of the
instructional intervention. These findings were also compared with the previous school
year’s QI findings in a frequency table. The after percentile scores are hypothesized to be
higher than the before scores, thereby providing evidence to support the effectiveness of
the instructional intervention. Recommendations were drawn from these data. A simple
nominal frequency scale was used for comparison of the total number of spirometry tests
per number of asthma records for each study period.
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Figure 12. SHC QI flow sheet. Used with the permission from Pamela Gross, MD, PhD
(Personal communication, November 30, 2010)
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Table 1.
Detailed Project Timeline
Time period
Spring semester 2011

Summer session 2011

Fall Semester 2011

Spring Semester 2012

Activities

Date completed

Contact NIH and obtain asthma topic related free
resource materials
Distribute provider resources for 2007 NAEPP EPR 3

January 5, 2011

Provider meeting presentation on SOAP note
template based on QI parameters, introduce
purpose of this DNP capstone project
Review EPR 3 highlights during March provider
meeting

January 21, 2011

After IRB approval, initiate EMR review: Retrieve
and review 50 random EMR for the period of 15 May
2010 to 14 May 2011 with asthma diagnosis

June 2011

Schedule for a clinical staff in-service: General
asthma topic and how we are managing asthma at
SHC

June 2011

Provide SHC staff (providers, nursing staff, IT and
pharmacist) with feedback regarding asthma SOAP
note use and evidence of students receiving ongoing
medication education by pharmacist and providers.

July 2011

Asthma education material placed in EMR

August 2011

The QI report based on data from the May 2011
records briefed to the staff, with a focus on areas of
improvement

August 2011

Ongoing refresher training, reminder notes handed
out

SeptemberDecember 2011

Retrieve and review 50 random EMR with asthma
(May 2011 to December 2011) diagnosis and
perform QI based on the existing SHC parameters

December 2011

The author starts data analysis process by
comparing QI findings from previous data

January 2012

Complete data analysis and start evaluation process

February 2012

Complete capstone project writing and submit to
appropriate authority
Present capstone findings to SHC staff

March 2012

46

January 21, 2011

March 18, 2011

March 2012

Figure 13. EMR – Spirometry. Adapted and used with permission from University of
North Carolina, Chapel Hill, Campus Health Services (Personal communication, May 19,
2011).
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Measurement of FEV1 when




A periodic check on the peak flow meter accuracy
Precision is desired when evaluating response to treatment or diagnosing
When peak flow results are unreliable, spirometry provides a quality check

Frequency of spirometry according to NAEPP EPR 3






At the time of initial assessment (Evidence C)
After treatment is initiated, and symptoms and PEF have stabilized, to document
attainment of near normal airway function
During a period of progressive or prolonged loss of asthma control
At least every 1-2 years to assess the maintenance of airway function (Evidence
B, extrapolation from clinical trials)
More often than every 1-2 years, depending on the clinical severity and response
to management (Evidence D)

Classification of asthma severity based on lung function
Persistent
Intermittent





Normal
FEV1
between
exacerbati
ons
FEV1 >80%
predicted
FEV1/FVC
normal

Mild




Moderate

FEV1 >80%
predicted
FEV1/FVC
normal





FEV1>60%
but <80%
predicted
FEV1/FVC
reduced 5%

Severe




FEV1 <60%
predicted
FEV1/FVC
reduced
>5%

Figure 14. Spirometry in-service for clinicians. Source: National Heart, Lung, and Blood
Institute. (2007, pp. 43, 269). National asthma education and prevention program expert
panel report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD:
National Institute of Health. National Heart, Lung and Blood Institute.
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As noted in Table 1, focused education and training activities for this project
began during the Spring semester, 2011. General asthma topics were presented, both
formally and informally, and clinicians received an NIH published (2007) summary of
NAEPP EPR 3 along with a summary highlights prepared by this author. Free asthma
related resource materials were obtained from the NIH and distributed to clinicians. At a
clinician meeting, the purpose of this DNP capstone project was introduced, and the
author presented a SOAP note template (see Figure 1) based on the QI parameters.
During a March clinician meeting the author reviewed NAEPP EPR 3 highlights.
At the beginning of Summer session, 2011, 50 EMRs were randomly selected
from eligible records for the period of May 15, 2010 to May 15, 2011 for the Spring 2011
data review. The author led in-service staff training events in June, July, and August
2011. The training provided SHC staff (clinicians, nursing staff, IT and pharmacist) with
general asthma knowledge, feedback regarding asthma SOAP note use and team roles in
student medication education by the pharmacist and the clinicians. During the August inservice, the Spring 2011 records review was briefed to the staff, with a focus on needed
areas of improvement in asthma management. Also in August, in coordination with IT,
an Asthma SOAP note template, an asthma care action plan, spirometry information
handouts, and patient discharge education materials were placed in the EMR system (see
Figures 5, 7, and 13).
During the Fall semester, 2011, ongoing refresher training was provided to the
staff, and occasional handouts served as reminders of asthma best practices. Numerous
attempts were made during this period to correct software and hardware problems with
the spirometry equipment, which were not resolved until the end of December 2011. At
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the end of this semester, 50 EMRs were randomly selected from eligible records for the
period of May 16, 2011 to December 16, 2011 for the Fall 2011 data review. This
concluded the study period of this project.
During January of the Spring semester, 2012, the author received the raw data
from the clinician performing the data review and started the data analysis process by
comparing the Fall 2011 findings with the earlier results from the Spring 2011 review and
the baseline QI from 2010. In March 2012, the completed project was submitted to a
faculty committee for approval. In April, the project results were briefed to the SHC staff
with emphasis on continuous quality improvement.
Project Tasks and Personnel
Staff Education
There were several staff asthma educational opportunities offered by the author,
and, a local allergy/asthma physician made presentations on asthma and spirometry topics
during Spring and Summer 2011. The staff education topic included general asthma
topics, medications, correct inhaler use, general spirometry information for staff, and
spirometry interpretations for providers (See Appendices A, B, and C; and Figure 14).
Projected Staff Education Topics
At the beginning of the project, the author selected focused staff education topics
based on weakness demonstrated in previous years SHC asthma QIs. These topics were
briefed in detail to the staff beginning with an in-service during the Spring semester 2011
and continuing through the Summer semester 2011. The first topic was NAEPP EPR 3
highlights review for youth ≥ 12 years of age and adults. This class emphasized
classifying asthma severity and initiating steps for treatment, discussing a stepwise
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approach for managing asthma, assessing asthma control, adjusting therapy, and
understanding the usual dosages for long-term control medications.
Another topic was the asthma care action plan. Clinicians were encouraged to
discuss with students an asthma care action plan as part of assisting students with selfmanagement. Providers were trained in the use of the care plan template provided by
NIH (See Figure 7). The care plan included utilizing peak flow meters and symptom
monitoring. This NIH action plan was simple to use and included patient information
material on the back.
Spirometry was a topic for ongoing training with material specific to clinicians
and the staff administering the spirometry tests. The clinician training focused on the
importance of spirometry data for asthma management. For the staff who performed
spirometry there was a need for continued training in the basic use of the equipment as
there were several changes in personnel during this period.
Clinician-specific topics included a sample SOAP documentation based on QI
parameters and training in how to use the electronic SOAP template. See Figure 1 for a
sample SOAP note. Hard copy patient education materials were available for each
provider and included the NIH Asthma Action Plan form, which includes environmental
control information, along with spirometry, peak flow meter, and inhaler use technique.
These hard copies were available until IT replaced them with a template in the EMR
during Summer session, 2011.
Resources and Support
The SHC provided the essential resources and support for this project. The SHC
director provided meeting space and designated staff time during the workweek for
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training events. With SHC institutional authorization and IRB exemption, the project had
access to EMRs for data analysis. Pre-existing spirometry equipment was utilized. IT
resources were utilized to place asthma templates in the EMR system.
Sustainability of the Proposed Project
No marketing or additional financial needs were involved for this project. The
author provided staff education as part of the SHC professional development in-service
training.
Plans for Maintaining/Sustaining the Change
Findings from the last EMR review were the basis for the next staff education
topic. During the summer sessions when there are fewer SHC daily patient visits, this
author gave staff training sessions, which included a power point review of the capstone
project. Clinician focused issues for ordering spirometry and medication were presented
during one of the monthly clinician meetings. Annual QI EMR review is ongoing.
Collaboration with the SHC care manager, IT, leadership and pharmacist were necessary.
Agency and IRB Approval
Statement of Mutual Agreement with Agency, Site, and Mentor
On February 15, 2011, the UNLV SHC institutional authorization to conduct
research was provided (see Appendix E), and permission to use the Johns Hopkins
Hospital/ The Johns Hopkins University JHNEBP Model PET process was obtained (see
Appendix F). The permission to use Deming’s PDSA cycle model is noted in Appendix
G. The project was reviewed by the UNLV Office of Research Integrity—Human
Subjects and deemed exempt as noted in Appendix H. Verbal and private email
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permission was obtained from Pamela Gross, MD, Ph.D. for the SHC QI parameter use.
The SHC director has a copy of the private email, which is available upon request.
IRB Approval or Exemptions as Appropriate
This study was deemed exempt from the institutional review board under 45 CFR
46.101(b) 4. See Appendix H.
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CHAPTER 5
SUMMARY OF IMPLEMENTATION AND RESULTS
Initiation of the Project
Upon approval of the project by the capstone committee chair, and supported by
the SHC director, staff education was planned and carried out as scheduled. Nursing staff
practiced spirometry testing during clinic slow time. Due to staff time constraints and
the complexity of the current spirometry equipment, the testing was not offered during
the initial patient visit, but was scheduled during two half days set aside in the week for
spirometry testing. Nursing staff recognized their role in asthma care during the intake
and clinicians had necessary information for the EMR review parameters and 2007
NAEPP EPR 3 guidelines. A clinician who is not part of this capstone project evaluated
the initial 50 EMR review (Spring 2011: 5/15/2010-5/15/2011) based on the 23
parameters used in the previous year’s asthma QI. The author and a research assistant
evaluated initial data analysis and subsequent staff education concentrated on the poorly
scored parameters. A patient information and asthma template was loaded into the EMR
during the fall 2011 semester. Ongoing clinical staff reinforcement was provided by
reminder sheets (see Figure 15), such as where the patient education templates were
located in the EMR, and by sample asthma SOAP notes. The second EMR review was
performed by the same clinician after the fall semester 2011ended (half the length of time
compared to the period of the previous study).
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Where are the asthma templates?
Subjective and Discharge Instructions (just select& check off) created in EMR templates.
Educational Bulletins created under the following transaction codes:
AsthmaAcPl = Asthma Action Plan Draft
AsthmaTrig = Asthma Triggers
SpirPtInfo
= Spirometry Patient Info
Asthma Subjective
Current medication:
Symptoms patient experiences:
Frequency of rescue inhaler use:
Symptom triggers:
Home Peak Flow Meter use OR Sx Mangt:
Spirometry status: Year:
ER visits/ hospitalization/Intubation History
Asthma Discharge Template
Patient educated regarding:
Control external/environmental triggers
Appropriate use of medication
Monitor frequency of rescue medication
Follow up sooner if increased rescue medication use (e.g. more than 2x/week)
New symptoms (e.g. nighttime awakening)
Spirometry testing every 1-2 years
Consider tapering steroid inhaler if symptoms controlled for 3 months
Schedule for spirometry without bronchodilator
Schedule for spirometry pre and post bronchodilator
Patient verbalized understanding of education
Patient exited in stable condition
Patient aware to follow up if further concerns

Figure 15. Patient handout reminder for staff.

Threats and Barriers to the Project
Although this is still the initial stage of a formal ongoing CQI process for asthma
at the SHC, this author recognizes several threats and barriers to this study. The first
threat to this study is that the 23 parameter tool was not tested for reliability or validity.
The 23 parameters were drawn from the 2007 NAEPP EPR 3 guidelines, and the
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presence of documentation in the EMR to support a particular parameter is assumed to
indicate the national guidelines were being followed in that a given appointment.
Another limitation of this study was the small number (n=25) of cases in the QI
that was used as a baseline. In order to compare the previous QI findings with the data
from the two capstone periods, which had 50 EMRs each, the author had to impute data
as if the baseline data were missing 25 cases. Imputing this number of cases may result
in biased estimates. Follow-up studies should be adequately powered. Also, there may
be a difference in subjective evaluation of raters. The EMRs from the baseline QI were
reviewed by the author and the two capstone project EMR reviews were performed by a
different clinician. The lower scores on certain parameters such as 5a, 5c, and 5d from
the baseline QI to the first capstone EMR review may be due to reviewer judgment
variances or extraneous variations such as clinician performance variability rather than
the asthma education effect.
A barrier encountered during the EMR review periods was significant SHC staff
turbulence due to the departure of the long-standing director and three nursing staff
members, including one of the most proficient spirometry test administrators. In addition,
during the time period of the project, the SHC went through an unexpected construction
process that altered patient care rooms week by week. The IT person was tied up
installing basic EMR required programs into different parts of the building, which
delayed the inclusion of the asthma education materials into the EMR until the fall
semester.
It should be noted that the pre-existing spirometry equipment was quite userunfriendly and technically challenging, and the SHC was not able to purchase new
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equipment due to limited funding during this period. Following the loss of three nursing
staff members, the nursing staff positions were vacant and the remaining staff had to
carry out their daily duties with less help. At the same time, the spirometry equipment
had technical issues and could not be used during most of the second study period.
Monitoring of the Project
The author coordinated with the SHC director on staff education
opportunities to ensure asthma education experiences complied with the project plan.
Over the course of the project, additional handouts and informal conversation with staff
were used to encourage application of the national guidelines in asthma management. To
ensure impartiality, a clinician in the SHC who was not directly involved in the capstone
project was asked to perform the random selection and scoring of the EMRs. Near the
end of the first period of project data collection (5/15/2010 to 5/15/2011), the author
spent several hours with the clinician who later analyzed the data (the data reviewer) to
demonstrate how the baseline QI data was gathered and how the 23 parameters were
scored. The author chose to compare random sets of 50 EMRs to compare the
effectiveness of ongoing staff education.
The post hoc power analysis suggested that 50 was an adequate number of EMRs
for data analysis. The data reviewer found 213 EMRs with asthma diagnosis and chose
every fourth record to arrive at the 50 EMRs necessary for review. After scoring, the raw
data, without patient identification, was presented to the author for statistical analysis. At
the end of the second period of the project data collection (5/16/2011 to 12/16/2011), the
data reviewer found 91 EMRs with asthma diagnosis, chose every other record, then
returned to the unselected records and chose every other record until 50 EMRs were
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chosen. There were fewer records to choose from because the second period was shorter
and did not include the spring semester.
Two aspects of the project fell behind schedule due to external factors. During
the summer semester of 2011, the asthma templates were scheduled to be placed on the
EMR system, but the IT office experienced employee turnover and a sharp increase in
workload. Eventually, negotiation aided by the SHC director gave the capstone project a
higher priority from IT and resulted in only a one-month delay and minimal effect on the
project. The other project delay was related to the in-house spirometry testing.
Throughout the second data collection period of the project, the spirometry equipment
experienced hardware and software computer problems, and there was a turnover in
nursing personnel resulting in a shortage of staff trained to use the equipment. These
problems were not resolved until the conclusion of the project data collection. However,
the effect on patient outcome resulting from the lack of in-house spirometry support is
beyond the scope of this capstone project. The data collection phase of the EMR review
for this capstone project concluded at the end of Fall semester 2011. Data evaluation was
completed in January 2012, and the statistical analysis was completed in March, 2012.
Data Analysis
Data were first tested for requisite assumptions, including univariate normality
(Skewness and Kurtosis) because repeated measures designs are particularly susceptible
to deviations of normality. The data approximated a normal distribution across all three
time points—Skewness and kurtosis values <

. Additionally, the data were screened

for univariate outliers. No outliers were detected. Additional testing procedures detected
several cases with missing data for the EMR review at baseline in the sample using IBM
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SPSS 19. The missing value analysis demonstrated 25 cases in the baseline EMR review
were treated as missing data to facilitate comparison with the other data reviews. The
intention to treat (ITT) analysis was utilized as the method for imputation of missing
data, as the data under consideration were dependent rather than independent—as in
between-subjects analyses. The ITT analysis is similar to imputation methods used in
analyses with independent data insofar as it minimizes the introduction of bias in missing
data imputation (Streiner, 2002). In this procedure, the participants’ score prior to
attrition was carried forward (i.e., last known observation is carried forward). Therefore,
50 cases were available for analysis for all three EMR reviews across time.
A repeated measures analysis of variance (RM ANOVA) was conducted on the
three EMR reviews (Spring 2009-2010; Spring 2010-2011; Fall 2011) in order to
examine the effectiveness of the teaching intervention as demonstrated in a review of
parameters based on 2007 NAEPP EPR 3 recommendation for asthma patients across
time. However, because the data violated the assumption of sphericity (Mauchly’s W =
.81, χ2 (2, N = 50) = 10.25, p < .01), the multivariate results of the within-subjects main
effect were interpreted in lieu of the univariate RM ANOVA results. Fisher’s Protected
t-test analyses were conducted to evaluate all possible pairwise comparisons of withinsubjects means. Fisher’s test corrects for familywise Type I error rate inflation via the
Bonferroni adjustment to the p-value (.05/3 within-subjects pairwise comparisons =
.016), due to the three unique within-subjects pairwise comparisons.
Data across all three EMR reviews were coded as 1 = Yes and 0 = No for each of
the 23 parameters of the chart review. A “yes” indicated the parameter in question was
covered in the asthma patient consultation whereas a “no” indicated the parameter was
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not covered. All not applicable responses were coded as 0, so as not to influence the
means. A summative score was subsequently obtained for all three EMR reviews by
adding all dimensions across charts, thus yielding a composite sum score with a possible
range from 0-23 per chart review. Therefore, a higher EMR score suggested the
parameters were appropriately covered with patients during consultations, whereas a
lower score suggested that not all parameters were appropriately covered, if at all.
Results
In order to ascertain differences in EMR reviews across the various semesters, an
RM ANOVA was conducted. In this analysis, data collection points served as the
independent variable and the EMR summative score served as the dependent variable.
The results demonstrated the change from EMR reviews across semesters was
statistically significant as indicated in Table 2. The Fall 2011 EMR reviews (M = 15.12,
SD = 4.34) demonstrate a higher EMR score than the EMR 2009-2010 reviews (M =
13.12, SD = 2.54) as well as the EMR Spring 2011 reviews (M = 11.84, SD = 3.27).
Post-hoc tests of within-subjects contrasts suggested the changes in EMR score between
Spring 2009-2010, Spring 2011and Fall 2011 were statistically significant as
demonstrated by the Cohen’s d values. This suggests the proposed training was effective
for improving overall evidence based practice with respect to asthma care.
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Table 2.
The Changes from EMR Reviews Across Semesters
Multivariate F = 9.37, p < 0.0005, η2p = 0.28, Wilk’s λ = 0.72
Spring 2009-2010

M = 13.12, SD = 2.54

Spring 2010-2011

M = 11.84, SD = 3.27

Fall 2011

M = 15.12, SD = 4.34

Post-hoc tests of within-subjects contrasts the change in EMR score
Spring 2009-2010 / Spring 2010- 2011

t = 2.54, p = 0.01, Cohen’s d = 0.44

Spring 2009-2010 / Fall 2011

t = -2.90, p < 0.01, Cohen’s d = -0.56

Spring 2010-2011 / Fall 2011

t = -4.33, p < 0.0005, Cohen’s d = -0.85

Giving Meaning to the Data
National guideline-based staff education was an effective method to improve
evidence based asthma management at the SHC. Although not all parameters reached
90%, the SHC goal for QI, the statistical analysis indicated significant improvement in
most of the 23 parameters. See Table 3 for the three period frequency comparisons.
While the baseline QI was not as statistically strong as the Spring and Fall 2011 QI
review performed during this project, it established the need for this project and served as
a guide for planning education topics for staff improvement in asthma management.
By the Fall 2011 period, the parameters that met the SHC 90% goal were current
medication list, current symptoms, frequency of rescue inhaler use, physical exam for
lungs, asthma diagnosis, and follow up interval. The other areas did not meet the 90%
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cut off, but with the exception of documentation of patient response after nebulizer
treatment, showed significant improvement compared to previous studies. The areas that
scored below 70% were indication of home peak flow use, prior PFT status, past
hospitalization history for asthma, patient response after nebulizer treatment, level of
asthma, written asthma action plan, controller medication, and recommendation of direct
follow up based on rescue inhaler use.
Among the parameters, which did not reach 70%, there were significant
improvements from the baseline. Indicated use of home peak flow meter use improved
from zero to 48%; prior PFT status increased from 32% to 42%; obtained medical history
of previous emergency room visit or hospitalization increased from 32% to 60%; asthma
level documentation increased from 24% to 50%; and asthma action plan went from zero
to 54%.
The author did not consider as “low performance areas” the parameters such as
administration of albuterol nebulizer treatment and documented response (3d); referral to
specialty (5f); and wean off unnecessary controller medication (5h). In these lowest
scored parameters, the documented responses may be a reflection of tool limitations. For
example, not all 50 EMRs had nebulizer treatment, but the EMR evaluator noted
presence (yes) or absence (no) of patient response after the treatment for those who
received treatment. The EMR evaluator entered “not applicable” (N/A) for records
without nebulizer treatment, but for statistical purposes, N/A and “no” were both coded 0.
One of the limitations of this tool is that these three parameters only indicate the presence
or absence of a condition or action and are not able to consider variables that might make
a trait positive or negative. While a few of the parameters might be refined to better
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measure appropriateness of the care received, the preponderance of evidence indicates
staff education improved evidence based asthma management at the SHC. Findings from
this study will be incorporated into the next staff education, and they will form the basis
for the next cycle of CQI EMR review.
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Table 3.
Frequencies of the 23 Parameters Based on NAEPP EPR 3 Recommendations
2010 (Baseline)
Spring %
(n=25)
88

Parameter

2011
Spring %
(n=50)
64

Fall %
(n=50)
76

100

100

96

1

1a ACT Score

2

1b Current medication

3

2a Symptom patient experiences

92

94

98

4

2b Frequency of rescue inhaler use

80

90

94

5

2c Indicated allergy symptoms or triggers

72

78

86

6

2d Indicated used of home Peak Flow Meter

0

14

48

7

2e Prior PFT status

32

14

42

8

2f Indicated PMH ER visit or hospitalization for asthma

32

40

60

9

3a Physical exam for upper airway

88

74

84

100

98

98

11 3c Measured Peak Flow reading and SaO2

92

68

72

12 3d Administration of albuterol nebulizer treatment and
documented response

28

22

6

100

100

98

24

38

50

0

18

54

16 5b Documented education about medications

92

50

74

17 5c Appropriately used controller medication

64

34

58

18 5d Discussed control of external triggers

60

28

78

19 5e Indicated follow up interval

88

98

90

20 5f Referred to specialty care

4

0

14

80

42

74

0

0

20

28

20

42

10 3b Physical exam for lung exam

13 4a Diagnosed with asthma
14 4b Documented level of asthma
15 5a Indicated written asthma action plan given to patient

21 5g Treated for comorbid conditions appropriate for asthma
22 5h Recommended wean off unnecessary controller
medications
23 5i Recommendation to direct follow up based on rescue
inhaler use
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Table 4.
2008-2011 SHC Spirometry Performance Table
Time period

Frequency

Note

5/18/20085/17/2009

10

Before SHC QI period

5/18/20095/14/2010

29

Initial staff spirometry education effective

5/15/20105/15/2011

39

Ongoing staff education

5/16/201112/16/2011

1

Spirometry malfunctioning and unable to
utilize

Dissemination and Utilization of Results
The findings of this capstone project will be shared with SHC staff during a staff
training event to be scheduled following project completion. The results will be
submitted for publication in a peer-reviewed journal. The study will be made available
online and may be included in professional online journals.
While this project has demonstrated improved, evidence based asthma
management in the SHC, it has also identified some areas for improvement in how the
national guidelines can be implemented in a university setting. As a CQI project, the
process of interventions and evaluation of effectiveness is a never-ending cycle.
Dialogue with staff members will be ongoing and input from the staff will be included in
plans to revise the parameters to more closely reflect the needs of the SHC population. In
addition, although it was not part of this study to assess how many students were utilizing
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peak flow meters and inhaler spacers, student comments indicate they seldom use these
important asthma management tools outside of the clinic. Most students rely on SABA
for symptom relief rather than using a PFM, which categorizes asthma symptom levels as
green, yellow, or red based on empirical standards as a measure of the effectiveness of
LABA. Reviewing a patient’s asthma action plan for each visit is not practical in a
university setting; a clinician review of medication may be more meaningful along with
advice to go to the nearest emergency department or Quick Care after clinic hours if they
experience asthma exacerbation. This study will be used as support for future grant
application for the purchase of user-friendly spirometry equipment, which can be used for
routine testing before rooming the patients rather than scheduling them to return for
another appointment just for spirometry. In order to increase spirometry use, it is
essential to offer it without charge, which will require applications for grants and a search
for other funding sources. Additional QI studies such as a provider-focused analysis or
an instrument-specific collection of data—for example, ACT scores or spirometry
results—will add strength to the evaluation of the quality of asthma management in the
SHC.
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APPENDIX A
STAFF EDUCATION POWERPOINT OUTLINE
Asthma
Hedian Swanson, MSN, FNP-BC
University of Nevada Las Vegas
Student Health Center
Asthma
(NHLBI, 2011)
Chronic inflammatory airway disease
Reversible but recurrent exacerbation decreases lung function more rapidly
Affects QOL, productivity and causes financial burden
Under controlled: over estimation of control, under treated
Prevalence
Estimated 300 M all ages, ethnic background suffer worldwide (GINA, 2011)
24.6 M (8.2%) Americans are affected (Akinbami, Moorman, & Liu, 2011)
6 million are children
8.6% in ACHA spring 2010 survey (ACHA, 2010)
<1% of SHC 2009-2010 (out of 19,000 visit)
Causes
Genetic factors
Environmental Factors (allergens)
Dust, animal fur, cockroaches, mold, pollens
Irritants: cigarette smoke, air pollution, chemical, dust, sprays,
Medication: ASA, NSAID, nonselective beta-blockers
Sulfites in food/drinks
Cold
Physical activity: EIA
Assessment
Common symptoms
Cough, wheezing, chest tightness, shortness of breath
Symptom history
Frequency of day time symptoms, nocturnal awakening, associated illness
Triggers
ER visits, hospitalization, intubation Hx
Peak Flow Meter readings
Room air pulse oximetry
Physical Exam
PFT
Bronchoprovacation
Diagnosis Category
Intrinsic/Extrinsic
Intermittent
Mild Persistent
Moderate Persistent
Severe Persistent
Exacerbation
Exercise Induced Asthma (EIA)
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Treatment
Medication: Stepwise Approach
Step Up, Step Down
SABA: Rescue Medication
LABA: Black Box warning.
ICS
ICS + LABA
Leukotriene receptor antagonist
Theophylline
Treatment for comorbidity
Immunotherapy
Patient education
Prevention: Control triggers, prevent exacerbation
Peak Flow Meter
Hand-held device: Readily available
Maximum Speed of Expiration
Measures the airflow through the bronchi, degree of obstruction in the airway
Age, Sex, Ht
Green, Yellow & Red Zone
Subjective- Effort dependent
Cleaning
Home: Wash in hot water and mild detergent once a week
Clinic: Concern for cross contamination
Why Spirometry?
Vital signs for lung function
Normal lung function declines during 20s
Asthmatic lung function sub-normal
Assessment for treatment effectiveness
SHC performed 29 spirometry in 2009-2010, 39 in 2010-2011(out of 219 asthma dx’d visits)
Spirometry
Asthma Action Plan
All students with asthma Dx should have one
Update every visit
SHC: Adapted from NIH Asthma Action Plan
Patient Education
Emergency Plan
Student Health Center & Asthma
Management
Thorough current Sx & past asthma Hx
Asthma Control Test for each visit
Pulse Ox, Peak Flow Meter, Current Rx
Appropriate Diagnosis
Appropriate Treatment: Step Up & Step Down
Educate Patients
Document
Spirometry every 1-2 years for well controlled
Student Health Center & Asthma Management (Cont’d)
EMR
SOAP Note: Subjective, discharge plan check list
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Order spirometry

Spirometry Pt handout
Asthma Action Plan
3 best values
Pre & Post if new Dx
Coach, coach & Coach!

2010-2011 EMR review by Ms. Dunne
Improved: Indicated peak flow use, Prior PFT, level of asthma, suggested f/u
Needs Improvement: Post neb tx response, controller Rx, Tx comorbid condition, Rx education
Conclusion
Asthma is a chronic inflammatory airway dz
Affect all ages & ethnic background
Can be controlled but Under controlled
SHC staff can make the difference
Monitor lung function
Recommend follow up
Educate the patients
References
Akinbami, L. J., Moorman, J. E., & Liu, X. (2011). Asthma prevalence, health care use, and mortality: United
states, 2005-2009. (National health statistics reports No. 32). Hyattsville, MD:
National Center for Health Statistics.
American College Health Association. (2010). American college health association-national college health
assessment II: Reference group executive summary. No. Spring 2010.
Linthicum, MD: American College Health Association.
The Global Initiative for Asthma (GINA, 2011). Global burden of asthma. Retrieved from
http://www.ginasthma.org/reports-global-burden-of-asthma.html
National Heart Lung and Blood Institute (NHLBI, 2011). Asthma, Retrieved from
http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/Asthma_WhatIs.html
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APPENDIX B
OUTLINE FOR SHC STAFF IN-SERVICE ON ASTHMA.
Asthma is “a common chronic disorder of the airways that is complex and characterized by variable
and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying
inflammation.” (NHLBI, 2007, p. 9)
Prevalence




300 million people in the world (WHO, 2006)
24.6 million Americans have asthma (Akinbami, Moorman, Liu, 2011)
8.8% college students reported asthma diagnosis or treatment within last 12 months
(ACHA, 2010)
 Less than 1% of visits in UNLV SHC 2009-2010 EMR review with asthma diagnosis:
Asthma is not one of the top 10 diagnosis in SHC, however, some EMR had ICD 9 codes
as shortness of breath, cough, medication refill, allergic rhinitis while PMH indicated
asthma (intrinsic or extrinsic).
 Our % is much lower than the national findings- Is that mean UNLV students are better
controlled with asthma?
Guideline-based asthma care: Attempt to improve and standardize the quality of care
NAEPP Expert Panel Report 3 Highlights
Severity, control and responsiveness to treatment
Severity: Impairment and risk, important to initiate proper treatment
Intermittent
Mild Persistent
Moderate Persistent
Severe Persistent
Control: Level of control guides decisions to either maintain or adjust therapy (Step up if
needed or step down if possible)
Monitor and reassess
Starting therapy or stepping up to regain asthma control: every 2-6 weeks
Controlled: every 1-6 months: review asthma control, medication technique, written
asthma care action plan, adherence and concerns at every visit
Education and partnership with students
Consider students’ culture and life style
Develop written asthma action plan and review with students
Integrate patient education in every visit (strength of SHC)
Patient education and reinforce: self monitoring via peak flow or symptoms, action plan,
medication used correctly (inhaler technique and device use such as spacer)
Control environment
Medications
Select medication and delivery devices to meet students’ needs and circumstances
Stepwise approach
ICS are part of the preferred treatment for persistent asthma
LABAs + ICS when stepping up therapy
All student using ICS/ICS + LABAs should have SABA
Long Term Management
Monitor:
 Signs and symptoms of asthma
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Pulmonary function: spirometry (at least every 1-2 years to assess the maintenance
of airway function), peak flow monitoring (moderate or severe persistent asthma,
history of severe exacerbation) or symptom based monitoring at home and during
office visit
Quality of life
History of asthma exacerbation
Medication adherence and potential side effect
Student-provider communication and student satisfaction

Review Student Health Center QI findings from 2009-2010 Academic year
See attachment
References for In-Service
National Heart, Lung, and Blood Institute. (2007). National asthma education and prevention program expert
panel report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National
Institute of Health. National Heart, Lung and Blood Institute.
American College Health Association. (2010). American college health association-national college health
assessment II: Reference group executive summary. No. Spring 2010. Linthicum, MD: American
College Health Association.
Akinbami, L. J., Moorman, J. E., & Liu, X. (2011). Asthma prevalence, health care use, and mortality: United
states, 2005-2009. (National health statistics reports No. 32). Hyattsville, MD: National Center for
Health Statistics.
World Health Organization (WHO). (2006). Fact sheet no. 307. Retrieved January 23, 2011, from
http://www.who.int/respiratory/asthma/scope/en/index.html
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APPENDIX C
CLINICIAN MEETING IN-SERVICE.
NAEPP EPR 3 Highlights
National Asthma Education and Prevention Program Expert Panel Report 3 (NAEPP
EPR 3) 2007 highlights
Severity: Important to assess asthma symptom severity to initiate right therapy
Symptoms: Nighttime awakenings, SABA use for symptom control (not prevention of EIB),
interference of normal activity, lung function
 Intermittent
 Mild, Moderate, Severe Persistent
Control: The goal for asthma therapy
 Consider step down if well controlled for at least 3 months
 Well Controlled: Risk for exacerbations requiring oral systemic
corticosteroids 0-1/year
Symptoms ≤ 2 days/week, nighttime awakenings ≤ 2x/month, no interference with
normal activity, SABA use ≤ 2x/week, FEV1 or peak flow >80% Predicted/personal best,
ACT ≥20
Impairment and risk are the 2 key domains of severity and control
Use multiple measures for assessment
Impairment: Frequency and intensity of Sx and functional limitations the pt is
experiencing currently or has recently experienced
Risk: Likelihood of exacerbation or progressive decline in lung function, or risk of AE
from medication
Management of Asthma
The course of the disease may change over time
Stepwise approach: 6 steps
Medication: Based on the 6 steps
ICSs: Preferred long-term control therapy for all ages
LABA + ICS equally preferred option (age 5 or older)
Omalizumab (Xolair) ≥12 : step 5 or 6 care (severe asthma)- refer to
asthma/allergy
Multifaceted Approach
Patient education: all points of care
Environmental Control: multifaceted approaches because single interventions are
generally
ineffective
Immunotherapy
Potential benefit to asthma control from treating comorbid conditions
Modifications to treatment strategies for managing asthma exacerbations
These are for urgent or emergency care setting: Severe exacerbation <40% predicted
FEV1 or PEF. Goal for discharge is a ≥70% predicted FEV1 or PEF. Encourage
development of pre-hospital protocols; modification of medication
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APPENDIX D
AGREE APPRAISAL INSTRUMENT NGC 5905
SCOPE AND PURPOSE (items 1 – 3)
1. The overall objective(s) of the guideline is (are) specifically described
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The objectives did not specify potential health impact of the guideline. It did focus on helping clinicians
and patients (Pt) make appropriate decisions about asthma care. Although this section did not describe in detail any
objectives related to preventing complications or lowering the risks, the recommendation section of the report included
some risk factors and quality of life issues.

2. The clinical question(s) covered by the guideline is(are) specifically described.
Strongly Agree

4

3

(2)

1

Strongly
Disagree

Comments: There is no specific clinical question in this CPG, but one needs to consider that this is one of the 4
components of the asthma care CPG using the Expert Panel Report 3 (EPR-3). This report is “Measure of asthma
assessment and monitoring” based on EPR-2 and EPR-3. However, it included specifics for an asthma action plan,
frequency of Peak Function Test (PFT), use of Peak Flow monitoring (PFM), frequency of follow ups, and questions
which form a basis for when referral to asthma specialist may be appropriate.

3. The patients to whom the guideline is meant to apply are specifically described.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The EPR-3 included generalized target population as infant, children, adolescents, and adults with asthma
without specific categories. It does not specify gender differences or populations with certain occupational exposure or
exercise induced asthma. For an example, sex matters in calculating PFM results and some patients experience
asthma symptom (Sx) only during exercise. However in the EPR-3 full report, it subcategorizes special groups in
treatment section.

STAKEHOLDER INVOLVEMENT (items 4-7)
4. The guideline development group includes individuals from all the relevant professional groups.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The Expert Panel on the Diagnosis and Management of Asthma members consisted mostly of MDs, with
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only one DNS RN and one PharmD listed in this CPG summary. Asthma is managed by nurse practitioners in primary
care on a daily basis and a more diverse representation is necessary.

5. The patients’ views and preferences have been sought.
Strongly Agree

4

3

2

(1)

Strongly
Disagree

Comments: This report does not include any Pt input on what is desired management for their health management, but
it is based on the clinicians’ informed judgment and on research findings.

6. The target users of the guideline are clearly defined.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The intended users were listed as APNs/nurses, allied health personnel, health plans, nurses, PAs and
respiratory care practitioners. It did not include educational institutions.

7. The guideline has been piloted among target users.
Strongly Agree

4

3

(2)

1

Strongly
Disagree

Comments: There was no indication of a pilot study among target users for further validation by the intended users.
This report is an update from EPR- 2 which was published in 1997 (with partial update in 2002). In the past 10 years
asthma related research has significantly expanded knowledge of this illness. This report reflected clinical judgment as
manifested by simplifying the various categories of severity of asthma.

RIGOUR OF DEVELOPMENT (items 8-14)
8. Systematic methods were used to search for evidence.
Strongly Agree

(4)

3

2

1

Strongly
Disagree

Comments: Hand searches of published primary sources and search of electronic databases were used over 3 cycles
in an 18-month period. It utilized inclusion and exclusion criteria and the literature review in broad spectrum initially,
then later were refined by using asthma related research publications. It also reflected the EPR-2 1997 and Update
2002 as the framework.
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RIGOUR OF DEVELOPMENT (cont)
9. The criteria for selecting the evidence are clearly described.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: It specified inclusion factors such as literature review from published Meta-analyses and English language
peer-reviewed medical journals in the MEDLINE database. They listed search terms and time frame, publication type
limits, and additional terms used to produce results that more closely matched the framework of topics and subtopics.
However it did not specify exclusion criteria, although the full report indicated that some titles and abstracts were
excluded during the review process. One can suppose that what is not in inclusion criteria may be the other, but
specifying the exclusion criteria would be helpful in further assessing why the particular area was not included in the
study.

10. The methods used for formulating the recommendations are clearly described.
Strongly Agree

(4)

3

2

1

Strongly
Disagree

Comments: This report clearly described the method used to formulate the recommendations and how the final
decisions were made. The expert consensus was used to formulate the recommendation and 8 steps were used to
develop the report including several layers of external review. The report was posted on the National Heart, Lungs,
and Blood Institute (NHLBI) web site for review and comments by the public and the National Asthma Education and
Prevention Program (NAEPP) coordinating committee.

11. The health benefits, side effects and risks have been considered in formulating the recommendations.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The report clearly identifies potential benefits from effective medical management of asthma for patients
and their families: improved lung function, reduced use of medications, increased self-management and quality of life
for patients and their families, and reduced use of health care services/interventions. No potential harms were stated.
However, it did consider risk factors related to lack of asthma education or biases that may be created by the patient’s
cultural experiences. The report discussed alternatives to spirometry such as PFM use for socioeconomically
underserved patients.

12. There is an explicit link between the recommendations and the supporting evidence.
Strongly Agree

(4)

3

2

1

Strongly
Disagree

Comments: The NAEPP provided ranking of evidence for recommendations based on the scientific literature and the
current evidence review, but NAEPP did not assign evidence rankings to recommendations “pulled through” from EPR2 (1997) for topics important to asthma diagnosis (Dx) and management; there was little new published literature. For
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an example: “The clinician, to establish Dx of asthma, should determine that episodic Sx of airflow obstruction are
present, airflow obstruction is at least partially reversible and alternative diagnoses are excluded” (EPR -2 1997)

13. The guideline has been externally reviewed by experts prior to its publication.
Strongly Agree

(4)

3

2

Strongly
Disagree

1

Comments: The summary stated that the draft of the EPR -3 was reviewed by a panel of expert consultants for their
review and comments. The revised draft of EPR was circulated to the NAEPP Guidelines Implementation Panel for
their comment. This draft was posted on the NHLBI Web site for public comment. According to the full report, the
Expert Panel considered 721 comments from 140 reviewers, went through another editing process before the full EPR
-3 was finalized and published in 2007.The full reference listing is available in the full report that I obtained through
NHLBI.

14. A procedure for updating the guideline is provided.
Strongly Agree

4

3

(2)

1

Strongly Disagree

Comments: No update guidelines are mentioned in the summary. In updating from EPR-2 to EPR-3, the report describes 3
literature review cycles during an 18 month period, and the following method was used to formulate the recommendations: (1) a
comprehensive search of the literature, (2) an in-depth review of relevant abstracts and articles, (3) utilization of evidence tables to
assess the weight of current and past recommendations, (4) discussion and interpretation of findings, (5) ranking strength of
evidence, (6) updating existing guideline with new findings from the evidence review, (7) external, NHLBI, and NAECP review
processes, and (8) preparation for the final report after the review cycle. The summary leaves one to assume that a similar
procedure will be followed to develop EPR-4.

CLARITY AND PRESENTATION (items 15-18)
15. The recommendations are specific and unambiguous.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: In general the EPR provides specifics of initial assessment for classification, but it is not clear how often to
categorize the pt by their Sx. The severity level can be interpreted differently among clinicians depending on what
questions they ask and how the Pt feels that day. For an example, a Pt can be categorized as “moderate persistent”
today, but could be place in a less severe category when the pt follows up with another provider. This can affect the
asthma treatment plan. Another ambiguity is that the report uses clinician and physician alternatively in the
recommendation section. Significantly, it states that the office based physician should have access to spirometry. In
my practice, I am the only provider who is certified with NIOSH approved spirometry training. Does that mean that only
a physician should have access to spirometry? It is not clear and sounds biased.
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16. The different options for management of the condition are clearly presented.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: Summarizing the detailed options listed in the full EPR-3 makes the recommendations in the summary
seem vague and imprecise. The recommendation for PFM use is somewhat confusing. The summary seems to
assume that all clinicians will ask appropriate questions to the Pt to correctly categorize asthma exacerbation.

17. Key recommendations are easily identifiable.
Strongly Agree

4

3

(2)

1

Strongly
Disagree

Comments: The formatting of the summary report makes it very difficult to follow where the different sections begin and
end. The headings and subtitles are blended together and are difficult to read. I ordered the full report (EPR-3) from
NHLBI and it was very helpful and much easier to follow from one topic to another. The full EPR would be a 4.

18. The guideline is supported with tools for application.
Strongly Agree

(4)

3

2

1

Strongly
Disagree

Comments: The summary report listed implementation tools which include foreign language translations, patient
resources, quick reference guides, physician (I think this term should be changed to “provider or clinician”) guides and
resources. The full report book has examples of each tool and is an excellent resource for primary care providers.

APPLICABILITY (items 19-23)
19. The potential organizational barriers in applying the recommendations have been discussed.
Strongly Agree

4

3

2

(1)

Strongly
Disagree

Comments: The EPR summary does not list organizational barriers although under the qualifying statement, it says
that the guidelines are intended to inform, not replace clinical judgment. Also, it recommends the clinician and the Pt
develop individual Tx plans specific to the needs and circumstances of the Pt.

20. The potential cost implications of applying the recommendations have been considered.
Strongly Agree

4

3

2

(1)

Strongly
Disagree

Comments: The EPR summary has no formal cost analysis nor was any published cost analysis reviewed. It is
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disappointing for me because the Expert Panel can recommend a systematic research based report for practice
guidance, but ignores the impact of the financial burden on the patient. The most difficult challenge I face in every day
practice is the cost of inhalers for short acting bronchodilators (SAB) or inhaled corticosteroids (ICS). This cost
contributes to poor compliance issues since more than 50% of my patients don’t have health insurance.

21. The guideline presents key review criteria for monitoring and/or audit purposes.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: The summary and full report includes clearly defined review criteria. It includes Sx, severity categories,
PFM parameters, Spirometry results (FVC, FEV1, FEV1/FVC, and FEV6), f/u recommendations and referrals and comanagement recommendations. The full report provides details on asthma assessment and monitoring criteria.
However, it does not include review criteria for audit purposes.

22. The guideline is editorially independent from the funding body.
Strongly Agree

4

(3)

2

1

Strongly
Disagree

Comments: Development of EPR-3 was entirely funded by the NHLBI and National Institutes of Health (NIH). The
guideline committees were NAEPP coordinating committee and the Third Expert Panel on the Dx and management of
asthma. The committees are under the big umbrella of the NIH

23. Conflicts of interest of guideline development members have been recorded.
Strongly Agree

(4)

3

2

1

Strongly
Disagree

Comments: The financial disclosures and conflicts of interest were listed in the report summary. I gave (4) for
presence of documentation, but I found it interesting to see how many physicians had financial disclosures or conflicts
of interest. Although the members were volunteers and received only transportation related expenses, most of them
(16/18 in summary listing) had some types of conflict of interest
FURTHER COMMENTS
Total score 66 (mean score 2.9): This was a valuable experience to learn in detail about the process of guideline
creation. Until I was exposed to this material, I assumed that the “guideline” was an absolute mandate for providing
best care to the patient. Now I realize that an educated person should look into further detail on how the
recommendation was created. Not all CPGs are equal. Although I complained about a lack of cost considerations in
#20, it is after all, the clinician’s informed judgment to tailor Pt care into a specific situation to bring out the best Pt
outcome. In all cases, the clinician must respect the Pt’s autonomy and final decision on treatment options
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APPENDIX E
UNLV INSTITUTIONAL PERMISSION
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APPENDIX F
JHNEBP MODEL & TOOLS PERMISSION

To: "'Hedian.Swanson@unlv.edu'" <Hedian.Swanson@unlv.edu>
From: "Gould, Lois" <lgould@son.jhmi.edu>
Date: 02/15/2011 08:46AM
Subject: Copyright Permission

(See attached file: AppendixD__PET.pdf)

Hello Hedian,
You have our permission to use the Johns Hopkins Nursing Evidence-based Practice
Model and Tools for your DNP capstone project. If you choose to use the Johns Hopkins
Nursing Evidence-based Practice Model and Tools in any other way, please submit a
request for that specific use. No modifications to the model or tools can be made
without permission. All reference to source forms should include “© The Johns Hopkins
Hospital/The Johns Hopkins University.”
Good luck…

Lois Gould
Manager, Continuing Education
The Institute for Johns Hopkins Nursing
525 North Wolfe Street, Room 532
Baltimore, MD 21205
(P) 410.614.1978 / (F) 410.614.8972
www.ijhn.jhmi.edu
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APPENDIX G
DEMING’S PDSA CYCLE USE PERMISSION

From: Pamela L Quick [mailto:quik@MIT.EDU]
Sent: Monday, February 13, 2012 8:49 AM
To: Hedian Swanson
Subject: Re: Hedian Swanson - Permission for PDSA Cycle copy

Dear Hedian Swanson,
Thank you for your message. I am happy to allow you to include the figure from THE NEW
ECONOMICS in your paper for the University of Nevada. Please credit the figure to W. Edwards
Deming, THE NEW ECONOMICS FOR INDUSTRY, GOVERNMENT, EDUCATION, 2nd edition, published
by The MIT Press. Please let me know if you have any questions.
Very best,
Pamela Quick
Permissions Manager

From: Diana Cahill [mailto:ddc@deming.org]
Sent: Sunday, February 12, 2012 6:59 PM
To: Hedian Swanson
Cc: Pamela L Quick
Subject: Re: Permission to Use

Dear Hedian,
I am grateful to you for making the change in your material to PDSA and am glad that
you have your own copy of The New Economics. I hope it is helpful to you.
You may use the PDSA cycle in your study but if you make an actual copy from the book,
permission must come from the publisher, MIT Press. Please send your request to
Pamela Quick at quik@mIT.EDU. I am certain that she will help you. Best wishes to
you on your project.
Sincerely yours,
Diana Deming Cahill
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APPENDIX H
UNLV IRB APPROVAL

Biomedical IRB – Exempt Review
Deemed Exempt
DATE:

June 6, 2011

TO:

Dr. Patricia Alpert, Nursing

FROM:

Office of Research Integrity – Human Subjects

RE:

Notification of review by /John Mercer/Dr. John Mercer, Chair
Protocol Title: Improving Evidence Based Asthma Management in an
Urban University Student Health Center
Protocol # 1104-3810

_______________________________________________________________________
___________
This memorandum is notification that the project referenced above has been reviewed as
indicated in Federal regulatory statutes 45CFR46 and deemed exempt under
45 CFR 46.101(b)4.
Any changes to the application may cause this project to require a different level of IRB
review. Should any changes need to be made, please submit a Modification Form.
When the above-referenced project has been completed, please submit a Continuing
Review/Progress Completion report to notify ORI – HS of its closure.
If you have questions or require any assistance, please contact the Office of Research
Integrity - Human Subjects at IRB@unlv.edu or call 895-2794.
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